Specifically, STAT3 protein levels in CAL33 and HN6 cells were higher than the other HNSCC cell lines, which were consistent with their response to the TSM-1 treatment (Figure 3C). This evidence concerns the gene STAT3 and head and neck squamous cell carcinoma.